press the down arrow to open sub-menu.
TOV is pleased to announce that nine NYU research and technology projects have been selected for the 2025 Technology Acceleration and Commercialization (TAC) Awards, a program designed to advance research excellence, technology transfer, and entrepreneurship at the University.
NYU’s Offices of Research Development and Technology Opportunities & Ventures (TOV) developed the initiative as part of NYU’s commitment to fostering innovation and translating academic research into real-world applications. The TAC Awards support applied research and technology projects for which intellectual property has been obtained (or will be sought) by NYU and that have strong potential for near-term commercialization.
The awards provide up to $75,000 in direct costs to support projects for up to one year. Proposals are required to address key technical, commercial, and financial aspects of the work to be funded and describe how the award will be used to advance the technology’s commercialization potential and market-readiness, such as through proof-of-concept studies and prototype development.
Projects that have commercial potential, in any field. The awarded projects in this track are:
Projects aligned with the Discovery Research Fund for Human Health established by the Office of Research Development to help make substantial progress toward understanding and improving health through research and innovation. The awarded projects in this track are:
The next cycle of the TAC Awards is expected to launch mid-year 2025. For more information about the awards or the awarded projects, contact TACFund@nyu.edu or visit the TAC Awards webpage.